Given that upregulated gastric inflammatory cytokines, such as TNF-α, IL-1β and IL-8 increase the risk of GC [7, 24], we next investigated whether GC-sensitive Bcl6b−/− mice had increased levels of inflammatory factors upon BaP treatment. The gene discussed is BCL6B; the disease is gastric cancer.